[Expression of the Fra-1 gene in the peripheral blood of children with Wilms tumor].

OBJECTIVE To study the expression of the Fra-1 gene in the peripheral blood of children with Wilms tumor and its clinical significance. METHODS Fifty children pathologically diagnosed with Wilms tumor between December 2012 and January 2018 were enrolled as the case group, and 40 healthy children for physical examination were selected as the control group. Among the 45 children with Wilms tumor who were followed up, the children with continuous remission were included in the ideal efficacy group (n=33), and those with recurrence, metastasis or death were included in the poor efficacy group (n=12). Peripheral blood samples were collected from all subjects. Quantitative real-time PCR was used to measure the mRNA expression of Fra-1. RESULTS The case group had significantly higher mRNA expression of Fra-1 in peripheral blood than the control group (P<0.05). In the case group, Fra-1 mRNA expression was significantly different between the individuals with and without distant metastasis and those with different TNM stages (P<0.05), but was not significantly different between the individuals with different sexes, ages, tumor diabetes, tumor locations and alpha-fetoprotein levels (P>0.05). The mRNA expression of Fra-1 was significantly lower in the ideal efficacy group than in the poor efficacy group (P<0.05). CONCLUSIONS Fra-1 may be involved in the development of Wilms tumor and plays a certain role in its development, invasion and metastasis, but the mechanism remains to be further studied.

[1]  Jonghwan Kim,et al.  Fosl1 overexpression directly activates trophoblast-specific gene expression programs in embryonic stem cells , 2017, Stem cell research.

[2]  Xia Fang,et al.  Fra-1 is upregulated in lung cancer tissues and inhibits the apoptosis of lung cancer cells by the P53 signaling pathway. , 2016, Oncology reports.

[3]  L. Wessels,et al.  Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival , 2015, Oncotarget.

[4]  U. Schumacher,et al.  Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties , 2015, Journal of Cancer Research and Clinical Oncology.

[5]  A. Lorenzo,et al.  Innovations in the management of Wilms’ tumor , 2014, Therapeutic advances in urology.

[6]  Elgene Lim,et al.  Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells. , 2013, Cancer cell.

[7]  Sridhar Ramaswamy,et al.  Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis , 2013, Proceedings of the National Academy of Sciences.

[8]  H. Matsubara,et al.  The molecular role of Fra‐1 and its prognostic significance in human esophageal squamous cell carcinoma , 2012, Cancer.

[9]  A. Sandler,et al.  Pediatric malignancies: neuroblastoma, Wilm's tumor, hepatoblastoma, rhabdomyosarcoma, and sacroccygeal teratoma. , 2012, The Surgical clinics of North America.

[10]  A. Dhillon,et al.  Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL , 2012, Oncogene.

[11]  Kai-Fu Tang,et al.  MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. , 2012, Carcinogenesis.

[12]  M. Rumi,et al.  FOSL1 Is Integral to Establishing the Maternal-Fetal Interface , 2011, Molecular and Cellular Biology.

[13]  R. Janknecht,et al.  Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells. , 2011, Biochimica et biophysica acta.

[14]  M. Brentani,et al.  Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma , 2011, Histopathology.

[15]  H. van Tinteren,et al.  Stromal and epithelial predominant Wilms tumours have an excellent outcome: The SIOP 93 01 experience , 2010, Pediatric blood & cancer.

[16]  A. Davidoff,et al.  Wilms' tumor , 2009, Current opinion in pediatrics.

[17]  E. Wagner,et al.  The role of the transcription factor AP-1 in colitis-associated and β-catenin-dependent intestinal tumorigenesis in mice , 2008, Oncogene.

[18]  P. Verde,et al.  Deciphering AP-1 Function in Tumorigenesis: Fra-ternizing on Target Promoters , 2007, Cell cycle.

[19]  S. Reddy,et al.  DEP-induced fra-1 expression correlates with a distinct activation of AP-1-dependent gene transcription in the lung. , 2004, American journal of physiology. Lung cellular and molecular physiology.